The present invention is directed to compounds that are inhibitors of cysteine proteases, in particular, cathepsins, B, K, L, F, and S and are therefore useful in treating diseases mediated by these proteases. The present invention is directed to pharmaceutical compositions comprising these compounds and processes for preparing them.
本发明涉及的化合物是半胱
氨酸
蛋白酶的
抑制剂,特别是
酪蛋白酶、B、K、L、F 和 S,因此可用于治疗由这些
蛋白酶介导的疾病。本发明还涉及包含这些化合物的药物组合物及其制备工艺。